Journal
CURRENT MOLECULAR MEDICINE
Volume 16, Issue 10, Pages 900-905Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1566524016666161223105201
Keywords
Sumoylation; genome stability; DNA damage response; synthetic lethality; cancer stem cell
Categories
Funding
- National Natural Science Foundation of China [81500738, 81570824]
- fundamental funds of the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University
Ask authors/readers for more resources
Sumoylation is a covalent protein posttranslational modification that conjugates the small ubiquitin-like peptide SUMO to substrate. Sumoylation is critically implicated in multiple biological processes, including cell proliferation, differentiation, senescence and apoptosis, etc. Therefore, it is not surprising that dysregulation of sumoylation has been implicated in tumorigenesis and different types of cancer were found to be addicted to functional sumoylation pathway. The potential role for sumoylation as a therapeutic target in caner is emerging. In this review, we summarize current knowledge regarding the involvement of sumoylation in genome stability and DNA damage response. We will further discuss the therapeutic potential of sumoylation as synthetic lethal partner and as a key signaling pathway in cancer stem cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available